Sneh Toprani | Radiation oncology | Women Researcher Award

Dr.Sneh Toprani | Radiation oncology | Women Researcher Award

Research Associate Harvard T H Chan Schol of Public Health  United States

Dr. Sneh Manishi Toprani is an Associate Research Scientist at Harvard University’s T.H. Chan School of Public Health. With a deep commitment to understanding DNA repair biomarkers, she has made significant strides in the field of genomics, radiation, and cancer biology. Her work is renowned globally, supported by prestigious grants, and recognized through numerous awards. Dr. Toprani is a green card holder, eliminating the need for visa or work sponsorship in the US.

Profile

Google Scholar


Education

🎓 Dr. Toprani’s academic journey began with a Bachelor’s in Biotechnology and Food Production & Processing (2006) and a Master’s in Biotechnology (2008) from the University of Mumbai. She later earned an Advanced Diploma in Clinical Research from Reliance Life Sciences (2010) and completed her Ph.D. in Life Sciences at the Bhabha Atomic Research Centre (2017). Her postdoctoral studies at Harvard University (2022) specialized in Genomics, Radiation, and Cancer Biology. Additional qualifications include diplomas in Fitness Consulting, an MBA executive program, and certifications in Patent Law, Project Management, and Scientific Writing.


Experience

💼 Dr. Toprani has a robust background in research and teaching. She currently serves as a Research Associate Scientist at Harvard University, where she investigates DNA damage and repair mechanisms. Her past roles include Radiation Oncologist collaborator at Brigham Women’s Hospital and MGH, Teaching Assistant at Harvard, and Research Associate at the University of Mumbai. She has also contributed as a Journal Club Facilitator and Project Assistant.


Research Interest

🔬 Dr. Toprani’s research is centered on DNA repair biomarkers, examining human sensitivity to DNA-damaging agents such as radiation, environmental mutagens, and nanoparticles. Her work aims to link these sensitivities with various diseases and cancer risks, contributing to the broader understanding of genomic stability and public health.


Awards

🏆 Dr. Toprani has received numerous accolades, including the Bharat Excellence Award and Leading Educationist Award of India with gold medals, the Rashtriya Vidya Gaurav Puraskar, and the Young Scientist Award. Her contributions have also been recognized with several travel and research awards, highlighting her impact and excellence in scientific research.


Publications

📚 Dr. Toprani has an extensive publication record, contributing to international peer-reviewed journals. Some of her notable works include:

  1. Toprani SM. et al (2024) “Cosmic Ionizing Radiation: A DNA damaging agent that may underly excess cancer in flight crew.” IJMS. 25(14): 7670. doi: 10.3390/ijms25147670
  2. Toprani SM. et al (2024) “Cosmic Ionizing Radiation: A DNA damaging agent that may underly excess cancer in flight crew.” Preprints. doi: 10.20944/preprints202406.0398.v1
  3. Brown N., …. Toprani SM. et al (2023) “Tuning ultrasmall theranostic nanoparticles for MRI contrast and radiation dose amplification.” Theranostics. 13(14):4711-4729. doi: 10.7150/thno.85663
  4. Singh R, Yu S, ….. Toprani SM. et al (2023) “Radiation therapy-induced neurocognitive impairment is driven by heightened apoptotic priming in early life and prevented by blocking BAX.” Cancer research. CAN-22-1337. doi: 10.1158/0008-5472.CAN-22-1337

 

Navdeep Dehar | Oncology | Excellence in Research

Dr.Navdeep Dehar | Oncology | Excellence in Research

Medical Oncologist Queens University Canada

Navdeep Dehar MBBS MD MBT FRCPC is an Assistant Professor in the Department of Oncology at Queen’s University and a Clinician Investigator & Medical Oncologist at the Cancer Centre of Southeastern Ontario. Additionally, he serves as a Precision Medicine Research Fellow at the Canadian Cancer Trials Group. With extensive training and experience in oncology, pharmacology, and biomedical technology, Dr. Dehar has made significant contributions to cancer research and clinical practice.

Profile

Scopus

Education

🎓 Education:

  • Subspecialty Training in Medical Oncology (2021-2023) – Queen’s University, Kingston, ON
  • Residency in Internal Medicine (2018-2021) – Cumming School of Medicine, University of Calgary, Alberta
  • Master of Biomedical Technology (MBT) (2012-2013) – University of Calgary, Alberta
  • Residency in Pharmacology – Doctor of Medicine (MD) (2005-2008) – Baba Farid University of Health Sciences, India
  • Bachelor of Medicine and Bachelor of Surgery (MBBS) (1998-2002) – Dayanand Medical College and Hospital, Baba Farid University of Health Sciences, India

Experience

💼 Experience:

  • Clinician Investigator & Staff Medical Oncologist (Locum) (July 2023 – present) – Cancer Centre of Southeastern Ontario, Kingston, ON
  • Assistant Professor of Medical Oncology (July 2023 – present) – Department of Medical Oncology, Queen’s University, Kingston, ON
  • Precision Medicine Research Fellow (October 2023 to September 2024) – Canadian Clinical Trials Group (CCTG), Kingston, ON
  • Medical Oncology Resident (2021-2023) – Queen’s University, Kingston, ON
  • Internal Medicine Resident (2018-2021) – University of Calgary, AB
  • Clinical Research Consultant (2013-2018) – GNR Biomedical Inc.

Research Interests

🔬 Research Interests:

  • Gastrointestinal Cancers
  • Neuroendocrine Tumors
  • Breast Cancer
  • Precision Oncology
  • Artificial Intelligence/Machine Learning in Oncology
  • Quality Improvement in Clinical Trials
  • Cancer Therapeutics with a Focus on Pharmacogenomics
  • Patient and Physician Education Initiatives
  • Global Oncology with a Focus on Quality Improvement

Awards

🏆 Awards:

  • Scholarship for Training in Lung Cancer (2023) – Canadian Lung Cancer Conference, Vancouver
  • Award of Appreciation for Extraordinary Contribution to Resident Redeployment Initiative during COVID Pandemic (2022) – Queen’s University, Kingston
  • Dr. Chirag Shah International Medical Graduate Award Recipient (2018) – Alberta International Medical Graduate Program, University of Calgary
  • Young Scientist Award (2008) – Sant Longowal Institute of Science and Technology, India

Publications

📚 Publications:

  • Dehar N, Gupta A, Singh G. “Comparative Study of the Efficacy and Safety of Ketorolac Tromethamine 0.5% Ophthalmic Solution and Diclofenac Sodium 0.1% Ophthalmic Solution in Patients of Acute Seasonal Allergic Conjunctivitis.” Int J Appl Basic Med Res. 2012 Jan-Jun; 2(1): 25–30. doi:10.4103/2229-516X.96799
  • Miriam Mutebi, Navdeep Dehar, Leticia M. Nogueira, Kewei Shi, K. Robin Yabroff,
    and Bishal Gyawali. Cancer Groundshot: Building a Robust Cancer Control Platform in
    Addition To Launching the Cancer Moonshot. American Society of Clinical Oncology
    Educational Book 2022:42, 1-16